[go: up one dir, main page]

MX2010003685A - Analogos de quinolona y metodos relacionados con los mismos. - Google Patents

Analogos de quinolona y metodos relacionados con los mismos.

Info

Publication number
MX2010003685A
MX2010003685A MX2010003685A MX2010003685A MX2010003685A MX 2010003685 A MX2010003685 A MX 2010003685A MX 2010003685 A MX2010003685 A MX 2010003685A MX 2010003685 A MX2010003685 A MX 2010003685A MX 2010003685 A MX2010003685 A MX 2010003685A
Authority
MX
Mexico
Prior art keywords
methods related
quinolone analogs
methods
present
compounds
Prior art date
Application number
MX2010003685A
Other languages
English (en)
Inventor
Jeffrey P Whitten
Fabrice Pierre
Mustapha Haddach
Johnny Yasuo Nagasawa
Michael Schwaebe
Levan Darjania
Original Assignee
Cylene Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cylene Pharmaceuticals Inc filed Critical Cylene Pharmaceuticals Inc
Publication of MX2010003685A publication Critical patent/MX2010003685A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se proporciona compuestos de quinolina novedosos y composición farmacéutica de los mismos que pueden inhibir la proliferación celular y/o inducir la apoptosis celular. La presente invención también proporciona métodos para preparar tales compuestos y composiciones, y métodos para hacerlos y usarlos.
MX2010003685A 2007-10-05 2008-10-03 Analogos de quinolona y metodos relacionados con los mismos. MX2010003685A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US97804207P 2007-10-05 2007-10-05
US3868108P 2008-03-21 2008-03-21
US4593308P 2008-04-17 2008-04-17
PCT/US2008/078859 WO2009046383A1 (en) 2007-10-05 2008-10-03 Quinolone analogs and methods related thereto

Publications (1)

Publication Number Publication Date
MX2010003685A true MX2010003685A (es) 2010-06-02

Family

ID=40523786

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003685A MX2010003685A (es) 2007-10-05 2008-10-03 Analogos de quinolona y metodos relacionados con los mismos.

Country Status (18)

Country Link
US (2) US7928100B2 (es)
EP (2) EP2214491B1 (es)
JP (2) JP5824213B2 (es)
KR (2) KR101601332B1 (es)
CN (1) CN101888780B (es)
AU (1) AU2008308485B2 (es)
BR (1) BRPI0817806A2 (es)
CA (1) CA2701630C (es)
DK (1) DK3092901T3 (es)
ES (2) ES2582662T3 (es)
IL (2) IL204844A (es)
MX (1) MX2010003685A (es)
NO (1) NO20100596L (es)
NZ (1) NZ584892A (es)
PL (2) PL3092901T3 (es)
PT (2) PT3092901T (es)
RU (1) RU2549895C2 (es)
WO (1) WO2009046383A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008131134A1 (en) * 2007-04-17 2008-10-30 Cylene Pharmaceuticals, Inc. Hydrazide compounds and uses thereof
PT3092901T (pt) * 2007-10-05 2020-05-21 Senhwa Biosciences Inc Análogos de quinolona e respetivos métodos relacionados
PL2470546T3 (pl) 2009-08-28 2013-12-31 Takeda Pharmaceuticals Co Związki heksahydrooksazynopterydynowe do zastosowania jako inhibitory MTOR
EP2480531B1 (en) 2009-09-21 2014-11-05 ChemoCentryx, Inc. Pyrrolidinone carboxamide derivatives as chemerin-r (chemr23) modulators
US8791107B2 (en) 2011-02-25 2014-07-29 Takeda Pharmaceutical Company Limited N-substituted oxazinopteridines and oxazinopteridinones
CN103533934B (zh) 2011-03-17 2016-03-30 特尔汗什莫尔医学基础设施研究和服务公司 用于治疗自身免疫性疾病的喹诺酮类似物
GB201206384D0 (en) * 2012-04-11 2012-05-23 Redx Pharma Ltd Antibacterial drug derivatives
CN104177379B (zh) * 2013-05-22 2016-12-28 中国科学院上海药物研究所 一种喹诺酮类化合物或其立体化学异构体、包含该化合物的药物组合物及其用途
WO2015079411A1 (en) 2013-11-28 2015-06-04 Tel Hashomer Medical Research Infrastructure And Services Ltd. Rna polymerase i inhibitors and uses thereof
CA2948173C (en) * 2014-05-09 2018-06-19 Pimera, Inc. Quinoline compounds and uses thereof
US9758518B2 (en) 2015-03-04 2017-09-12 Pimera, Inc. Compositions, uses and methods for making them
CN119185322A (zh) * 2015-11-20 2024-12-27 生华生物科技股份有限公司 用于治疗癌症的四环喹诺酮类似物组合疗法
US9957282B2 (en) * 2015-12-14 2018-05-01 Senhwa Biosciences, Inc. Crystalline forms of quinolone analogs and their salts
TWI765848B (zh) * 2015-12-14 2022-06-01 生華生物科技股份有限公司 喹諾酮類似物及其鹽的結晶形式
CA3006502A1 (en) * 2015-12-14 2017-06-22 Senhwa Biosciences, Inc. Crystalline forms of quinolone analogs and their salts
CN116077439A (zh) 2016-04-29 2023-05-09 西奈山伊坎医学院 靶向先天免疫系统以诱导长期耐受性及解决动脉粥样硬化中的巨噬细胞累积
CN110709400A (zh) 2017-03-28 2020-01-17 皮梅拉股份有限公司 Pol1抑制剂的新型晶体形式
US11071727B2 (en) 2018-01-26 2021-07-27 Northwestern University Therapeutic targeting of proteolytic cleavage of the mixed lineage leukemia gene product (MLL1) by taspase1 using kinase inhibitors
RU2020130050A (ru) * 2018-02-15 2022-03-15 Сэньхва Байосайенсиз, Инк. Аналоги хинолонов и их соли, композиции и способ их применения
WO2020051342A1 (en) * 2018-09-06 2020-03-12 Cornell University Methods for treating metastatic disease using ribosome biogenesis inhibitor cx 5461
CA3151116A1 (en) * 2019-08-14 2021-02-18 Hshiou-Ting Liu Crystalline forms of quinoline analogs and salts thereof, compositions, and their methods for use
KR20220130085A (ko) 2019-08-14 2022-09-26 센화 바이오사이언시즈 인코포레이티드 테트라사이클릭 화합물 및 이의 염, 조성물, 및 이의 사용 방법
JP2020189888A (ja) * 2020-08-28 2020-11-26 センワ バイオサイエンシズ インコーポレイテッド キノロン類似体及びその塩の結晶形
US12274700B1 (en) 2020-10-30 2025-04-15 Accencio LLC Methods of treating symptoms of coronavirus infection with RNA polymerase inhibitors
CN114573604B (zh) * 2020-12-01 2024-06-18 中国科学院上海药物研究所 一类基于喹诺酮的化合物、其制备方法、包含其的药物组合物及其用途
US11859021B2 (en) 2021-03-19 2024-01-02 Icahn School Of Medicine At Mount Sinai Compounds for regulating trained immunity, and their methods of use
CN114409681A (zh) * 2022-03-18 2022-04-29 信义核新(北京)生物科技有限公司 用于治疗dna损伤修复缺陷肿瘤的喹诺酮类似物及其应用
WO2024222630A1 (zh) * 2023-04-23 2024-10-31 信义核新(北京)生物科技有限公司 喹诺酮衍生物及其在抗肿瘤中的应用
WO2024222147A1 (zh) * 2023-04-23 2024-10-31 信义核新(北京)生物科技有限公司 喹诺酮类似物及其用途
WO2025114459A1 (en) * 2023-11-28 2025-06-05 Genome Therapeutics Ltd Tetracyclic compounds for use in antibody-drug conjugates for the treatment of cancer
WO2025133338A1 (en) * 2023-12-21 2025-06-26 Genome Therapeutics Ltd Quinolone derivatves against cancer

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
ATE269848T1 (de) 1999-04-07 2004-07-15 Univ Virginia Calciumkanalblocker als antikrebsmittel
AU2002361493A1 (en) 2001-12-13 2003-06-23 Wockhardt Limited New generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
AU2004278320B2 (en) * 2003-09-22 2010-06-24 Janssen Pharmaceutica, N.V. 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
MX2007003282A (es) * 2004-09-17 2007-10-16 Cylene Pharmaceuticals Inc Analogos de quinolona.
PT1928887E (pt) * 2005-08-05 2015-02-12 Senhwa Biosciences Inc Métodos de preparação de análogos de quinolona
CA2619663A1 (en) * 2005-08-19 2007-02-22 Cylene Pharmaceuticals, Inc. Human ribosomal dna(rdna) and ribosomal rna (rrna) nucleic acids and uses thereof
AR057555A1 (es) * 2005-10-27 2007-12-05 Merck Frosst Canada Ltd Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo
US20090291437A1 (en) * 2005-11-02 2009-11-26 O'brien Sean Methods for targeting quadruplex sequences
US20100063046A1 (en) * 2006-05-17 2010-03-11 Whitten Jeffrey P Tetracyclic imidazole analogs
US20100305136A1 (en) * 2006-06-08 2010-12-02 Johnny Yasuo Nagasawa Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
US20110112086A1 (en) 2006-06-08 2011-05-12 Cylene Pharmaceuticals, Inc. Pyridinone analogs
GB0701992D0 (en) 2007-02-02 2007-03-14 7Tm Pharma As Grehlin Receptor Modulators
WO2008131134A1 (en) * 2007-04-17 2008-10-30 Cylene Pharmaceuticals, Inc. Hydrazide compounds and uses thereof
PT3092901T (pt) * 2007-10-05 2020-05-21 Senhwa Biosciences Inc Análogos de quinolona e respetivos métodos relacionados

Also Published As

Publication number Publication date
NO20100596L (no) 2010-06-10
KR20100064392A (ko) 2010-06-14
DK3092901T3 (da) 2020-05-18
EP2214491A1 (en) 2010-08-11
US7928100B2 (en) 2011-04-19
IL204844A (en) 2017-01-31
KR101601332B1 (ko) 2016-03-08
EP2214491B1 (en) 2016-07-13
KR101682867B1 (ko) 2016-12-05
US8853234B2 (en) 2014-10-07
JP5824213B2 (ja) 2015-11-25
EP3092901A1 (en) 2016-11-16
ES2582662T3 (es) 2016-09-14
CA2701630A1 (en) 2009-04-09
CN101888780A (zh) 2010-11-17
PT3092901T (pt) 2020-05-21
JP2010540663A (ja) 2010-12-24
RU2010117225A (ru) 2011-11-10
KR20160020578A (ko) 2016-02-23
PL3092901T3 (pl) 2020-10-19
HK1150728A1 (en) 2012-01-13
RU2549895C2 (ru) 2015-05-10
JP2014159474A (ja) 2014-09-04
CN101888780B (zh) 2014-08-13
BRPI0817806A2 (pt) 2014-10-07
PL2214491T3 (pl) 2016-11-30
US20110218184A1 (en) 2011-09-08
EP2214491A4 (en) 2010-11-10
PT2214491T (pt) 2016-10-25
AU2008308485A1 (en) 2009-04-09
US20090093455A1 (en) 2009-04-09
AU2008308485B2 (en) 2014-08-07
CA2701630C (en) 2016-10-25
IL249906A0 (en) 2017-03-30
ES2791305T3 (es) 2020-11-03
EP3092901B1 (en) 2020-04-29
NZ584892A (en) 2012-06-29
IL249906B (en) 2020-10-29
IL204844A0 (en) 2010-11-30
WO2009046383A1 (en) 2009-04-09

Similar Documents

Publication Publication Date Title
MX2010003685A (es) Analogos de quinolona y metodos relacionados con los mismos.
JOP20180102A1 (ar) مركب صيدلاني
PH12017500660A1 (en) Novel compositions, uses and methods for making them
MY153915A (en) Organic compounds
WO2011032169A3 (en) Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
SG179085A1 (en) Pi3 kinase inhibitors and uses thereof
MY194262A (en) Inhibitors of ret
MX354402B (es) Inhibidores de molecula pequeña del dominio de homologia de pleckstrin y metodos para usar los mismos.
TW201713640A (en) Bruton's tyrosine kinase inhibitors
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
UA97502C2 (ru) Кристаллическая твердая основа разагилина
MY148634A (en) Pyridazinone derivatives
MY181898A (en) Heterocyclic compounds and uses thereof
IN2014DN09346A (es)
MX2012002366A (es) Agonistas novedosos de receptores beta 3 andrenergicos derivados de pirrolidina.
PH12012501346A1 (en) Heteroaryl compounds and uses thereof
TN2009000255A1 (en) Quinazolines for pdk1 inhibition
GB2453058A (en) Kinase antagonists
NO20090596L (no) Antivirale fosfinatforbindelser
MX2007005221A (es) Formas cristalinas de ascomicina y preparacion de ellas.
EA201401193A1 (ru) Триарильные соединения и композиции, их содержащие
MX336726B (es) Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintasa quinasa-3.
MX2009010174A (es) Derivados de aza-adamantano ester y carbamato y metodos de uso de los mismos.
MX2017011116A (es) Composiciones novedosas, usos y metodos para hacerlas.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal